Rubella medical therapy

Rubella Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Rubella from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Treatment
Medical Therapy
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Case Studies
Case #1
Rubella medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Rubella medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Rubella medical therapy
CDC on Rubella medical therapy
Rubella medical therapy in the news
Blogs on Rubella medical therapy
Directions to Hospitals Treating Rubella
Risk calculators and risk factors for Rubella medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aravind Kuchkuntla, M.B.B.S[2]

Overview

There is no specific antiviral therapy for rubella infection. Symptomatic therapy and reporting of the infection to the local disease control agencies is recommended.

Treatment

• There is no specific antiviral therapy for rubella infection.
• Health care providers should perform the following when diagnosis of rubella is suspected:
  • Consider rubella in unvaccinated patients with febrile rash illness and other rubella symptoms, especially if the person recently traveled internationally or was exposed to a person with febrile rash illness.
  • Promptly isolate people suspected to have rubella and report them to the local health department.
  • Collect throat (best source), nasal, or urine specimens for viral detection by polymerase chain reaction (PCR) testing and molecular typing, and blood for serologic testing.